erythromycin has been researched along with Leukemia, Myelomonocytic, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| CSERHATI, I; KELEMEN, E; RAK, K | 1 |
| Cid, A; Jarque, I; Martín, G; Pérez-Bellés, C; Salavert, M; Sanz, MA | 1 |
2 other study(ies) available for erythromycin and Leukemia, Myelomonocytic, Acute
| Article | Year |
|---|---|
[Detailed study of serum prothrombopoietin and patients with acute erythro-myelosis and thrombocytopenia].
Topics: Blood Platelets; Erythromycin; Humans; Leukemia, Myelomonocytic, Acute; Polycythemia Vera; Thrombocytopenia | 1960 |
Recurrent bacteremia caused by Rhodococcus equi in a non-neutropenic patient with acute myeloid leukemia in complete remission.
Topics: Actinomycetales Infections; Adult; Amikacin; Bacteremia; Catheters, Indwelling; Ceftazidime; Cilastatin; Drug Resistance; Drug Therapy, Combination; Erythromycin; Female; Humans; Imipenem; Immunocompromised Host; Leukemia, Myelomonocytic, Acute; Neutropenia; Pneumonia, Bacterial; Recurrence; Rhodococcus equi; Vancomycin | 2002 |